We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance and information about high consequence infectious diseases and their management in England.
RSV vaccines are 82% effective for older people and 72% for newborns when mothers are vaccinated at least 14 days before birth.
Information on the spring 2025 campaign for eligible individuals.
Influenza vaccines marketed in the UK for 2025 to 2026, including ovalbumin content.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
Meningococcal immunisation information for public health professionals.
Information about the meningococcal B (MenB) vaccine and paracetamol use.
Guidance on assessing risk following rabies exposure, post-exposure treatment, and public health management of a suspected rabies case in the UK.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Varicella immunisation information for public health professionals, including updates.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .